Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)

NCT02878057 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Cancer Hospital & Institute

Collaborators